GSK Settles Avandia Heart Attack Case on Trial’s Eve

GlaxoSmithKline Plc (GSK) said it settled on the eve of trial a lawsuit alleging its Avandia diabetes drug caused a North Carolina man to die of a heart attack, avoiding a jury determination over risks associated with the medicine.
San Francisco Chronicle